FACTS ABOUT MBL77 REVEALED

Not all individuals with CLL demand therapy. Despite all latest improvements, the iwCLL however recommends watchful observation for patients with asymptomatic disorder.86 This recommendation is based on at least two randomized trials evaluating observation to either chlorambucil monotherapy or fludarabine, cyclophosphamide and rituximab (FCR).103,1